Synthesis of the reported structures for kealiinines B and C

Organic Letters

Volumn 14, Issue 18, 2012, Pages 4734-4737

  Gibbons, Joseph B ^a   Gligorich, Keith M ^b   Welm, Bryan E ^b   Looper, Ryan E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; GUANIDINE; KEALIININE B; KEALIININE C;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; OXIDATION REDUCTION REACTION; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; CYCLIZATION; GUANIDINE; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; STEREOISOMERISM;

EID: 84868228171     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol3019242     Document Type: Article

References (30)

1. Sullivan, J. D.; Giles, R. L.; Looper, R. E. Curr. Bioact. Compd. 2009, 5, 39.
2. Koswatta, P. B.; Lovely, C. J. Nat. Prod. Rep. 2011, 28, 511.
3. Dunbar, D. C.; Rimoldi, J. M.; Clark, A. M.; Kelly, M.; Hamann, M. T. Tetrahedron 2000, 56, 8795.
4. Copp, B. R.; Fairchild, C. R.; Cornell, L.; Casazza, A. M.; Robinson, S.; Ireland, C. M. J. Med. Chem. 1998, 41, 3909.
5. James, R. D.; Jones, D. A.; Aalbersberg, W.; Ireland, C. M. Mol. Can. Ther. 2003, 2, 747.
6. Mancini, I.; Guella, G.; Debitus, C.; Pietra, F. Helv. Chim. Acta 1995, 78, 1178.
7. Carroll, A. R.; Bowden, B. F.; Coll, J. C. Aust. J. Chem. 1993, 46, 1229.
8. Fu, X.; Schmitz, F. J.; Tanner, R. S.; Kelly-Borges, M. J. Nat. Prod. 1998, 61, 384.
9. Hassan, W.; Edrada, R.; Ebel, R.; Wray, V.; Berg, A.; van Soest, R.; Wiryowidagdo, S.; Proksch, P. J. Nat. Prod. 2004, 67, 817.
10. Akee, R.; Carroll, T.; Yoshida, W.; Scheuer, P.; Stout, T.; Clardy, J. J. Org. Chem. 1990, 55, 1944.
11. (a) Kawasaki, I.; Taguchi, N.; Yamashita, M.; Ohta, S. Chem. Pharm. Bull. 1997, 45, 1393.
12. (b) Koswatta, P. B.; Lovely, C. J. Chem. Commun. 2010, 46, 2148.
13. (c) Lima, H. M.; Sivappa, R.; Yousufuddin, M.; Lovely, C. J. Org. Lett. 2012, 14, 2274.
14. Gainer, M. J.; Newbold, N. R.; Takahashi, Y.; Looper, R. E. Angew. Chem., Int. Ed. 2011, 50, 684.
15. Ermolat'ev, D. S.; Bariwal, J. B.; Steenackers, H. P. L.; De Keersmaecher, S. C. J.; Van der Eycken, E. V. Angew. Chem., Int. Ed. 2010, 49, 9465.
16. For leading references, see: (a) Wei, C.; Li, Z.; Li, C.-J. Synlett 2004, 1472.
17. (b) Zani, L.; Bolm, C. Chem. Commun. 2006, 4263.
18. (c) Li, C.-J. Acc. Chem. Res. 2010, 43, 581.
19. (d) Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem., Int. Ed. 2002, 41, 2535.
20. (e) Gommermann, N.; Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem., Int. Ed. 2003, 42, 5763.
21. Both aryl acetaldehydes are commercially available or obtainable by the LiAlH4 reduction of the more readily available phenylacetic acid to the alcohol, followed by IBX oxidation to the aldehyde. See: Pelphrey, P. M.; Popov, V. M.; Joska, T. M.; Beierlein, J. M.; Bolstad, E. S.; Fillingham, Y. A.; Wright, D. L.; Anderson, A. C. J. Med. Chem. 2007, 50, 940.
22. Guibe, F.; Garro-Helion, F.; Merzouk, A. J. Org. Chem. 1993, 58, 6109.
23. Horwell, D.; Guo, Z.; Cammidge, A. Synth. Commun. 2000, 40, 2933.
24. (a) Padwa, A.; Lee, H.; Rashatasakhon, P.; Rose, M. J. Org. Chem. 2004, 69, 8209.
25. (b) Nicolaou, K. C.; Prasad, C. V. C.; Somers, P. K.; Hwang, C. K. J. Am. Chem. Soc. 1989, 111, 5330-5334.
26. (c) Bedford, S. B.; Bell, K. E.; Bennett, F.; Hayes, C. J.; Knight, D. W.; Shaw, D. E. J. Chem. Soc., Perkin Trans. 1 1999, 15, 2143.
27. A similar donation strategy has been used to favor 5-endo-dig over 5-exo-dig cyclizations. David, W. K.; Redfern, A. L.; Gilmore, J. Tetrahedron Lett. 1998, 39, 8909.
28. LaBarbera, D. V.; Modzelewska, K.; Glazar, A. I.; Gray, P. D.; Kaur, M.; Liu, T.; Grossman, D.; Harper, M. K.; Kuwada, S. K.; Moghal, N.; Ireland, C. M. Anticancer Drugs 2009, 20, 425.
29. Budihardjo, I.; Oliver, H.; Lutter, M.; Luo, X.; Wang, X. Annu. Rev. Cell Dev. Biol. 1999, 15, 269.
30. Chae, H. J.; Kang, J. S.; Byun, J. O.; Han, K. S.; Kim, D. U.; Oh S.M.;Kim,H.M.;Chae, S.W.;Kim,H.R. Pharmacol. Res. 2000, 42, 373.